Corpay, Inc. CPAY

Ronald Clarke, chief executive of Corpay, was paid $3,406,867 in 2025 on a $1,369,231 salary plus an equity bonus worth zero to $4,000,241. The larger number sits off that table, 650,000 options struck at $150.74 expiring January 25, 2027.

What the plan pays for

Two metrics remove acquisitions from the measurement and the third pays for signing them, which tells him to buy at almost any price. Deal value counts the day papers are signed while the cost is stripped out of the earnings line that grades him.

The record

The acquisition weight went from a quarter of the bonus to a third for 2024, with the target up a third too. Signed value has tripled since. Metric changed, behavior followed, which is causal evidence rather than coincidence, though a fuller deal pipeline is a plausible competing cause. The committee cut the payout in 2023 and 2024, then let the largest year run untouched. Discretion has only run one direction.

Pace is comfortably ahead. First-half 2026 revenue of $2,599.8 million is up 23.3% on $2,107.7 million, against full-year consensus of $5,315 million. Both 2025 bars were set under the street, revenue against a $4,516 million estimate and earnings against $21.28. The market funded that payout before the board wrote it down.

What Clarke does next

Sign more deals before December. Agreements count at signature and closing risk belongs to next year, so watch fourth-quarter 8-Ks still unclosed at proxy time.

Keep the buyback running into January. Corpay repurchased $782.8 million of stock in 2025 while spending $1,933.8 million on acquisitions, and every dollar of it supports a price that decides $171.1 million of his own money. Watch the third-quarter share count.

Reach for announcements that move the price without capital. Capital expenditure ran $200.8 million on $4.53 billion of revenue, so headline partnerships cost nothing beside it. Watch the press release count against a capital line that does not move.

Exercise the rest before the January expiry. Watch the Form 4s.

The move that pays him damages the owner in the same breath. Signing $3.2 billion of deals in one year against $3.5 billion of book equity, with goodwill at $7.15 billion and debt at $10.62 billion, leaves the shareholder carrying integration risk the scorecard never measures.

The insiders

Clarke exercised 200,000 options at $150.74 in May 2026, code M, withholding 136,637 shares near $350 to cover, code F. No code S appears against his name. He kept the stock, holds 2,408,233 shares, and has not sold one in twelve months. On July 22, 2026 he received three new derivative awards of 100,000 units each, terms not yet in any proxy. Everyone below him goes the other way. Alan King exercised and sold 44,208 shares in August near $412, code M then S, about $18.2 million. Armando Netto exercised and sold 70,476 shares in June at $352.13 and separately sold 21,761 owned shares near $355, code S alone, roughly $7.7 million. Directors Joseph Farrelly sold 5,300 near $410 and Jeffrey Sloan 3,600 at $343.62. Steven Stull bought 8,000 at $314.98 in December, the only open-market purchase on the tape, and had sold all 8,000 back by August between $361 and $415.

An owner is paying this chief executive for the size of the check he signs rather than for what the check buys, and he has five months of option clock left to sign more of them.

Yellow.

Sources: Corpay DEF 14A filed 2026-04-10, 2025-04-30, 2024-04-26 (CIK 1175454). Forms 4 filed 2025-09-30 through 2026-08-20, transaction codes read from raw XML. Revenue, cash flow and balance sheet per as-filed statements through the quarter ended 2026-06-30. Price and consensus per FMP as of 2026-08-24. Derived figures (option intrinsic value, first-half growth, half-year revenue sums, sale-price averages) are computed. Not investment advice. No position.